News: Archives

Fibrinolytic Therapy for Heart Attacks May Offer Advantages During COVID-19 Pandemic 04.29.2020

For patients experiencing an ST-Elevation Myocardial Infarction (STEMI), the medical term for a heart attack, time is muscle. “When a clot closes the coronary artery, the heart muscle starts dying, and patients can experience chest pain and other symptoms,” said Mauricio Cohen, M.D., professor of medicine and director of the Cardiac Catheterization Laboratory at the University of Miami Miller School of Medicine.

Read more about the therapy »

Dr. Daniel Mintz, founding scientific director of Diabetes Research Institute, passes away 04.28.2020

Scientists, physicians and countless patients mourn the passing of Daniel H. Mintz, M.D., emeritus professor of medicine at the University of Miami Miller School of Medicine and scientific director emeritus of the Diabetes Research Institute.

Read more about Dr. Daniel Mintz »

Miller School Immunologists Identify How Dosing Strategy Improves Effectiveness of Malaria Vaccine 04.28.2020

A team of immunology researchers at the University of Miami Miller School of Medicine has uncovered a mechanism of immune protection for the RTS,S/AS01 malaria vaccine that could lead to an effective malaria vaccination program for children.

Read more about the study »

UM Offers Stem Cells to Treat COVID-19 Patients with Life-Threatening Respiratory Infections 04.24.2020

For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal stem cell (MSC) treatments that may help fight the characteristic inflammation that accompanies the viral infection.

Read more about the treatment »

UHealth to Offer Convalescent Plasma with COVID-19 Antibodies for Seriously Ill Patients 04.23.2020

A new initiative by infectious disease experts and researchers with the University of Miami Health System offers convalescent plasma with COVID-19 antibodies as a treatment for patients who are seriously ill from the coronavirus infection or at serious risk of progression.

Read more about the treatment »

New Grant Targets Global Health Protection Against the Spread of Infectious Diseases 04.21.2020

The AIDS Healthcare Foundation Global Public Health Institute at the University of Miami has awarded José Szapocznik, Ph.D., chair emeritus of the Miller School of Medicine’s Department of Public Health Sciences, a grant to develop a project to promote global health protection against the spread of infectious diseases.

Read more about the grant »

Miller School Makes Exceptions for Medical School Applicants During an Exceptional Time 04.16.2020

Because of the COVID-19 pandemic, the University of Miami Miller School of Medicine has relaxed some requirements for college seniors applying to medical school, including acceptance of pass/fail grades for current classes.

Read more about the exceptions »

New Cell Therapy Trial Launches for Patients with Severe COVID-19 04.15.2020

An international team of scientists led by Camillo Ricordi, M.D., director of the Diabetes Research Institute and Cell Transplant Center at the University of Miami Miller School of Medicine, was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells to block the life-threatening lung inflammation.

Read more about the clinical trial »

Miller School Researchers Alert Otolaryngologists about High COVID-19 Transmission Risk 04.14.2020

A harsh reality has emerged as COVID-19 has spread around the globe. Several thousand doctors, nurses and others caring for COVID-19 patients are dying from the virus. To alert providers in otolaryngology, one of the hardest-hit medical specialties, about the high risk of transmission and how to avoid it, University of Miami Miller School of Medicine researchers studied data from China.

Read more about the research »

Cutting-Edge Research Finds Targets for New Glaucoma Treatments 04.13.2020

Glaucoma increases intraocular pressure (IOP) in the eyes, eventually damaging the optic nerve and often leading to irreversible blindness. Eyedrop and pill medications can reduce IOP by limiting eye water production or increasing its outflow, but the root causes for most glaucomas are unknown, and there are no cures.

Read more about the research »

Page 1 of 439 pages  1 2 3 >  last »